Search
Products
Community
Markets
News
Brokers
More
IN
Get started
GLENMARK PHARMACEUTICALS
Long
Aug 14, 2020
GLENMARK - Q1 RESULTS AND OBSERVATIONS
0
Grab this chart
Grab this chart
Q1 2020, results
Financials Q1 FY2020-21 Q1 FY2019-20 % Change
Total Income ₹ 2403.30 crs ₹ 2324.54 crs Up Tick 3.39%
Net Profit ₹ 254.04 crs ₹ 109.28 crs Up Tick 132.47%
EPS ₹ 9 ₹ 3.87 Up Tick 132.56%.
THE FACTOR FOR 3% INCREASE IN TOP LINE IS NOT SO GOOD. BUT, THE PANDEMIC SITUATION SALES ARE GOOD. Q2 SHOULD BE FURTHER IMPROVED.
Sunandamedi
Follow
Also on:
Beyond Technical Analysis
Chart Patterns
Technical Indicators
Sunandamedi
Follow
Also on:
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the
Terms of Use
.